As Pandemic Wanes, Firms That Rode C0VID-19 Testing Wave Struggle for Solid Footing

Companies that once rode high on the COVID-19 pandemic may now have to face the possibility of extinction in the coming years.

Article By Greg Cima / March 7, 2023

Companies that once rode high on the COVID-19 pandemic may now have to face the possibility of extinction in the coming years.

View PDF

News

Outcome Capital has won honors as the Top Life Sciences Advisory & Investment Banking Firm – 2024 per Life Sciences Magazine

Outcome Capital has won honors as the Top Life Sciences Advisory & Investment Banking Firm – 2024 per Life Sciences Magazine January 2024   Read the full article from Life Science Magazine here: Read More

Read More
Resources

Outcome Capital Life Sciences Pulse, March 2024

Outcome Capital Life Science Market Pulse March 2024 Click to view our LifeSciences Pulse Newsletter

Download

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    20 Custom House St, Suite 1200, Boston, MA 02110
    (617) 431-2278

© Outcome Capital 2024. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.

Business Continuity Plan | Privacy Policy | Regulation Best Interest

Built by Metropolis